- FAVORIS
-
- EXPLORE
-
-
-
-
-
-
- Male
- 17/12/2000
- Suivi par 0 people
Mises à jour récentes
- DelveInsight Pressure Ulcer Treatment Market 2032: Clinical Trials, Regulatory Approvals, Market Trends, and Emerging TherapiesMajor players in the pressure ulcer treatment market include Phagelux, MiMedx, EyeGene, Shionogi & Co., NovaLead Pharma, Smith & Nephew PLC, Integra LifeSciences, Baxter International, Molnlycke Health Care AB, Cardinal Health, Essity Aktiebolag, 3M Company, B. Braun Melsungen, ConvaTec Group, and Coloplast Group. Overview of the Pressure Ulcer Treatment Market (Albany, USA)...0 Commentaires 0 partsPlease log in to like, share and comment!
- Severe Atopic Dermatitis Market Expected to Experience Significant Growth from 2024 to 2034, Report DelveInsight | Sun Pharma, Galderma, Eli Lilly, Sanofi, AstraZeneca, Pfizer and Other Leading Companies of Severe atopic dermatitis marketAs per the latest research by DelveInsight, it is expected to see significant expansion over the forecast period (2024-2034).Key players contributing to this growth include Sun Pharmaceutical Industries, Galderma, Eli Lilly, Sanofi, AstraZeneca, Pfizer, and several other major pharmaceutical companies. DelveInsight Comprehensive Reporting"Severe Atopic Dermatitis Market Insights, Epidemiology...0 Commentaires 0 parts
- DelveInsight Pressure Ulcer Treatment Market 2032: Clinical Trials, Regulatory Approvals, Market Trends, and Emerging TherapiesMajor players in the pressure ulcer treatment market include Phagelux, MiMedx, EyeGene, Shionogi & Co., NovaLead Pharma, Smith & Nephew PLC, Integra LifeSciences, Baxter International, Molnlycke Health Care AB, Cardinal Health, Essity Aktiebolag, 3M Company, B. Braun Melsungen, ConvaTec Group, and Coloplast Group. Overview of the bedsore treatment market (Albany, USA) DelveInsight's...0 Commentaires 0 parts
- Skin Burn Treatment Market 2034: Clinical Trials, Regulatory Approvals, Market Trends, and Emerging Therapies by DelveInsightSmith+Nephew, Mölnlycke Health Care AB, Convatec Inc., 3M, Coloplast Group, Medtronic, Accell Group, Anika, Therapeutics, Inc. Braun Melsungen AG, Cardinal Health, DeRoyal Industries, Hollister, Integra LifeSciences Corporation, Medline Industries, Inc., PAUL HARTMANN AG, Essity Aktiebolag, Avita Medical, Suwelack Skin and Health Care AG, FortHealthpoint Worth、Advanced...0 Commentaires 0 parts
- Vitiligo Therapeutics Market Outlook 2034: Regulatory Approvals, Pipeline Analysis, Market Trends, Key Industry Players - DelveInsight ResearchLeading vitiligo drug developers include Incyte, Abbvie, Pfizer, Clinuvel, Bioniz Therapeutics, TAGCyx Biotechnologies, Temprian Therapeutics, Aclaris Therapeutics, TWi Biotechnology, Dermavant Sciences, Amgen, and others. Vitiligo Treatment Market (Albany, USA) DelveInsight's comprehensive report, "Vitiligo Market Insights, Epidemiology, and Market Forecast - 2034," provides a detailed...0 Commentaires 0 parts
- According to DelveInsight analysis, the Dystrophic Epidermolysis Bullosa market is expected to witness significant growth between 2024 and 2034 |Major players include Krystal Biotech, Chiesi, Phoenix Therapeutics, Aegle Therapeutics, Anterogen, and others.Prominent Dystrophic Epidermolysis Bullosa market participants include Krystal Biotech, Chiesi, Phoenix Therapeutics, Aegle Therapeutics, Anterogen Co., Abeona Therapeutics, Inc, Castle Creek Bioscience, Phoenix Tissue Repair, Inc., Scioderm, Inc., InMed Pharmaceuticals, and others. DelveInsight's comprehensive report, "Dystrophic Epidermolysis Bullosa Market Insights, Epidemiology, and Market...0 Commentaires 0 parts
- Acne Vulgaris Market Forecast to 2034: Regulatory Approvals, Disease Prevalence, Clinical Research, Treatment Options, Key Industry Players - DelveInsight AnalysisLeading acne vulgaris companies, including Ortho Dermatologics, Bausch Health, Galderma Labs, Timber Pharmaceuticals, BioPharmX, Kintor Pharma, Botanix Pharmaceuticals, Dermata Therapeutics, AstraZeneca, Novartis Pharmaceuticals, UCB Pharma, Incyte Corporation and others, are aggressively pursuing the treatment space. Acne vulgaris treatment market (Albany, USA) DelveInsight's extensive report,...0 Commentaires 0 parts
- Prurigo Nodularis Treatment Market Outlook 2034: Clinical Trials, Regulatory Approvals (FDA, EMA, PDMA), Emerging Therapies, Epidemiology, MOA, Market Revenue, Leading Companies InsightsKey players in the Prurigo Nodularis situation: Trevi Therapeutics、Galderma、Genentech、Incyte Corporation、Vyne Therapeutics Inc.、Celgene Corporation、Novartis、Pfizer、Regeneron Pharmaceuticals など。 Overview of the Prurigo Nodularis Treatment Market (Albany, USA)– Title of DelveInsight’s latest report"Prurigo Nodularis Market Insights, Epidemiology, and Market Forecast - 2034."It offers...0 Commentaires 0 parts
- Chronic Urticaria Treatment Market 2032: Clinical Trials, Regulatory Status (FDA, EMA, PDMA), Drug Market Dynamics, Prevalence, Pipeline Treatments, Key Statistics, Key Players – DelveInsightKey Players in the Chronic Urticaria MarketMajor pharmaceutical companies active in the chronic urticaria field include Sanofi-Aventis, Merck, UCB, Regeneron, Roche, Principia Biopharma, Novartis, AstraZeneca and Kyowa Kirin. Overview of the chronic urticaria treatment market (Albany, USA)- DelveInsight's "Chronic Urticaria – Market Insights, Epidemiology, and Market Forecast –...0 Commentaires 0 parts
- Dermatomyositis Drugs Market 2034: Clinical Trials, FDA, EMA, PMDA Approvals, Treatment Status, Epidemiology, Emerging Therapies, Market Insights, Key Players by DelveInsightSkin and muscle inflammation companiesThese include AstraZeneca, Bristol-Myers Squibb, Pfizer, Octapharma AG, Corbus Pharmaceuticals, Ermium Therapeutics, Kezar Life Sciences, Neovacs, Horizon Therapeutics, Priovant Therapeutics, CSL Behring, Alexion, Idera Pharmaceuticals, Galapagos NV, EMD Serono, Japan Blood Products Organization, Mallinckrodt, Genentech, Astellas Pharma, Biogen, and several...0 Commentaires 0 parts
Plus de lecture